PCOS Has a New Name: What PMOS Means and Why It Changes Everything

What Is PMOS?

PMOS stands for Polyendocrine Metabolic Ovarian Syndrome. The name was adopted following a global consensus process led by Professor Helena Teede at Monash University, involving 56 patient and professional organisations, including the Endocrine Society, and contributions from researchers across dozens of countries.

Breaking down the new name tells you exactly what changed in the understanding of this condition:

• Polyendocrine: Affecting multiple endocrine (hormone-producing) systems, not just the ovaries
• Metabolic: Fundamentally a metabolic disorder involving insulin resistance, glucose regulation, and energy metabolism
• Ovarian: The ovaries are still involved, but they are not the starting point of the problem
• Syndrome: A collection of symptoms and signs, not a single disease with one cause

The old name, Polycystic Ovary Syndrome, described a feature that many women with the condition do not even have. The new name describes what the condition actually is.

Why the Old Name Was Wrong All Along

The word "polycystic" suggested that having multiple cysts on the ovaries was the defining characteristic of the condition. Two problems with that.

First, the structures seen on an ultrasound in women with this diagnosis are not cysts. They are follicles: small fluid-filled sacs that contain eggs in early development. Having more follicles than average is not the same as having abnormal cysts. The name conflated two very different things.

Second, and more significantly: many women with PCOS by every hormonal and metabolic measure do not show these follicles on ultrasound at all. Research confirmed there is no increase in abnormal ovarian cysts in the condition. The defining feature of the old name was not actually a defining feature.

The result was decades of misunderstanding. Patients were told they had a problem with their ovaries. Treatment focused on managing menstrual symptoms or supporting fertility. The underlying metabolic dysfunction, which is what creates the real long-term health risks, was often left unaddressed.

What PMOS Actually Is: A Metabolic Condition First

The core of PMOS, in the majority of cases, is insulin resistance. The body produces insulin but the cells do not respond to it efficiently. To compensate, the pancreas produces more insulin. High insulin levels then drive the ovaries to produce more androgens (testosterone and similar hormones), which disrupts the menstrual cycle, causes symptoms like acne and hair changes, and creates the hormonal environment that makes this condition so difficult to manage with generic advice.

This is why standard calorie-restriction diets often fail women with PMOS. This is why women with PMOS can exercise intensively and not lose weight in the expected way. The metabolic starting point is fundamentally different from a woman without insulin resistance.

The full list of systems PMOS affects includes:

• Reproductive function and menstrual regularity
• Insulin sensitivity and blood sugar regulation
• Weight distribution and fat storage patterns
• Skin health (acne, skin tags, darkened patches)
• Hair growth patterns (excess facial or body hair, hair thinning on the scalp)
• Mental health (higher rates of anxiety and depression)
• Long-term cardiovascular risk
• Risk of type 2 diabetes (up to 7 times higher than average)
• Sleep quality (higher rates of sleep apnoea)

None of these are primarily about ovarian cysts. They are all consequences of hormonal dysregulation and metabolic dysfunction.

How the Name Change Happened

The push to rename PCOS did not happen overnight. It was the culmination of years of frustration from both patients and researchers who felt the old name was actively misleading people about the nature of the condition.

Professor Helena Teede, who led the international consensus process, described the old name as reflecting "only ovarian aspects" while "overlooking broader features" of the condition. The research process involved over 22,000 survey responses from patients, doctors, nurses, dietitians, psychologists, and other professionals. The goal was to find a name that was medically accurate, acceptable to patients, and useful for driving better treatment.

The Endocrine Society, one of the most respected bodies in hormonal medicine, was among the 56 organisations that endorsed the change. The process was published in The Lancet in 2026.

What This Means If You Have Been Diagnosed

If you were diagnosed with PCOS, your diagnosis is still valid. You do not need to be re-tested or re-diagnosed. PMOS is the same condition. The biology has not changed. What has changed is the medical framework for understanding and treating it.

In practical terms, what this should mean for your care:

• Your doctor should be assessing your metabolic health, not just your reproductive health
• Insulin resistance should be tested and addressed, not assumed away
• Long-term cardiovascular and diabetes risk should be discussed explicitly
• Mental health support should be part of care, not an afterthought
• Exercise and nutrition recommendations should be tailored to insulin resistance, not generic

If your current doctor is still treating this primarily as a reproductive condition, the name change gives you a stronger basis to ask for metabolic screening and a more comprehensive approach.

Why This Changes the Approach to Exercise

Understanding PMOS as a metabolic condition changes everything about how exercise should be approached.

Generic exercise advice (do more cardio, eat less) does not account for insulin resistance. Women with PMOS who follow standard fat-loss programmes often see worse results than women without the condition, not because they are not trying hard enough, but because the programme was not designed for their metabolic reality.

The exercise approach for PMOS needs to target insulin sensitivity directly. Strength training does this more effectively than any other form of exercise, because contracting muscles can absorb glucose from the bloodstream without requiring insulin. This is a direct bypass of the dysfunction at the core of PMOS.

Excessive high-intensity cardio, on the other hand, raises cortisol, which worsens insulin resistance and drives androgen production. For someone with PMOS, this can actively make the condition harder to manage.

For a full breakdown of what exercises work, what to avoid, and a 4-week training plan built around the metabolic needs of PMOS, see the complete PCOS and PMOS exercise guide.

The Diagnostic Criteria Has Not Changed

One important clarification: the criteria used to diagnose PMOS are the same as those used to diagnose PCOS. To receive a diagnosis, a woman typically needs to show two of the following three features:

1. Irregular or absent menstrual periods
2. Clinical or biochemical signs of elevated androgens (like high testosterone, excess hair growth, or acne)
3. Polycystic ovarian morphology on ultrasound (the follicle pattern, despite the name)

The Rotterdam criteria, which have guided diagnosis since 2003, remain in use. What the name change addresses is not how you are diagnosed, but how the condition is understood and treated once the diagnosis is made.

What Should Change in Treatment Going Forward

The renaming should accelerate a shift that has already been happening gradually in progressive medical practices. Treatment for PMOS should now be understood as primarily metabolic management, with reproductive support as one component.

Specifically, the most important changes:

Lifestyle as First-Line Treatment

Diet and exercise are not optional additions to medication. They are the most effective interventions available for PMOS, particularly for improving insulin sensitivity. A 5 to 10 percent reduction in body weight in women who are overweight has been shown to restore menstrual regularity and reduce androgen levels significantly. This happens because reducing fat mass, particularly visceral fat, directly reduces insulin resistance.

Metformin Is Being Reconsidered

Metformin, an insulin-sensitising medication originally developed for type 2 diabetes, has been used off-label for PCOS management for years. As PMOS is formally recognised as a metabolic condition, the case for metformin as a first-line option (rather than an afterthought) becomes stronger in appropriate cases.

Mental Health Is Part of the Condition

Women with PMOS have significantly higher rates of anxiety, depression, and disordered eating than the general population. These are not separate conditions that happen to coincide. They are part of the PMOS picture. The name change supports a more integrated treatment approach that includes psychological support as standard, not as a referral only when things have become severe.

A Condition That Affects Far More Women Than Most People Know

PCOS affects between 8 and 20 percent of women of reproductive age globally, depending on the diagnostic criteria used. In India, prevalence estimates range from 9 to 22 percent, meaning tens of millions of women are affected.

Despite this, the condition has historically been under-researched, under-diagnosed, and under-treated. The average time from first symptoms to diagnosis has been between 2 and 3 years in many countries. Women are often told their symptoms are normal, or that the only relevant question is whether they want to get pregnant.

The renaming to PMOS is, in part, an attempt to change this. A condition with a clearer, more accurate name is easier to take seriously, easier to explain to patients, and easier to build comprehensive treatment protocols around.

What to Do Now

If you have a PCOS diagnosis or suspect you might have this condition, the name change does not change what you should do. It does give you clearer language to use with your doctor and a clearer framework for understanding what your body is doing.

The most important steps remain the same:

• Request metabolic screening: fasting insulin, glucose tolerance, HbA1c, full lipid panel
• Start strength training if you are not already. It is the most direct intervention for insulin resistance
• Prioritise protein intake at every meal to support insulin sensitivity
• Reduce ultra-processed foods and refined sugars
• Address sleep. Poor sleep worsens insulin resistance significantly
• Consider tracking your hormonal patterns over time with tools like the Hormone Tracker

For a full evidence-based exercise plan designed specifically around the metabolic needs of PMOS, the PCOS and PMOS exercise guide covers exactly what works, what to avoid, and how to structure your training week.

Frequently Asked Questions